HPLC-MS/MS analysis of ilimaquinone and its application in a pharmacokinetic study in rats

J Pharm Biomed Anal. 2019 Mar 20:166:291-294. doi: 10.1016/j.jpba.2019.01.030. Epub 2019 Jan 17.

Abstract

Ilimaquinone, a metabolite isolated from the marine sponge Hippiospongia metachromia, has antimicrobial, cytotoxic, anti-HIV, anti-inflammatory, and anti-cancer activities. A new quantitative analytical method for determination of ilimaquinone in rat plasma using HPLC-MS/MS was developed and validated. Ascorbic acid was added to ensure the stability of ilimaquinone in plasma. After protein precipitation using acetonitrile plus diclofenac as an internal standard, the analytes were chromatographed on a biphenyl column with a mobile phase of methanol and water (8:2, v/v, including 0.1% formic acid). This method was successfully applied in a pharmacokinetic study of ilimaquinone after oral administration in rats.

Keywords: Ilimaquinone; LC–MS/MS; Rat plasma; Stability.

MeSH terms

  • Administration, Oral
  • Animals
  • Chromatography, High Pressure Liquid
  • Drug Stability
  • Porifera / chemistry
  • Quinones / administration & dosage
  • Quinones / blood
  • Quinones / isolation & purification
  • Quinones / pharmacokinetics*
  • Rats, Sprague-Dawley
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Sesquiterpenes / administration & dosage
  • Sesquiterpenes / blood
  • Sesquiterpenes / isolation & purification
  • Sesquiterpenes / pharmacokinetics*
  • Tandem Mass Spectrometry

Substances

  • Quinones
  • Sesquiterpenes
  • ilimaquinone